Market Scope

Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Over 500 Clients, Large & Small from Around the World, Have Trusted Market Scope Data & Analysis

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

9/22/2023
BreakingClinical TrialPharmaRetina
Two-Year Results for Izervay Show Continued Slowing of GA Growth
Two-Year Results for Izervay Show Continued Slowing of GA Growth

Iveric Bio, an Astellas company, reported on Sept. 18 positive 24-month topline results from the Phase III GATHER2 trial of Izervay (avacincaptad pegol), its treatment for geographic atrophy (GA) s...

9/22/2023
BreakingCataractDry EyeGlaucomaIndustryPharma
Mati Completes Facility to Manufacture Evolute Punctal Plug Portfolio
Mati Completes Facility to Manufacture Evolute Punctal Plug Portfolio

Mati Therapeutics, of Austin, Texas, reported Sept. 12 that it had completed a 10 thousand square foot facility in Bryan, Texas, to manufacture the company’s Evolute sustained drug delivery platfor...

9/22/2023
BreakingDealsPharma
Novartis Readies Spinout of Sandoz, a Leading Provider of Generic Ophthalmic Drugs
Novartis Readies Spinout of Sandoz, a Leading Provider of Generic Ophthalmic Drugs

Swiss company Novartis reported Sept. 15 that its shareholders had approved its spinoff of Sandoz, its generics and biosimilars business. The target date for the spinoff is Oct. 4. Sandoz is a lead...

9/21/2023
CataractEnvironmentMeetingNewsletter
2023 ESCRS Congress Pits Greener Choices Against Traditional Practices to Fight Waste
2023 ESCRS Congress Pits Greener Choices Against Traditional Practices to Fight Waste

Eye surgeons swapped their scrubs for boxing robes at the 2023 congress of the European Society of Cataract and Refractive Surgeons, as they took part in the society’s high-profile battle against s...

9/22/2023
BreakingDiagnosticRetina
US FDA Clears Expanded FA Capabilities of NeoLight’s Portable Retinal Camera Icon Go
US FDA Clears Expanded FA Capabilities of NeoLight’s Portable Retinal Camera Icon Go

NeoLight announced Sept. 12 that the US FDA had cleared the expanded fluorescein angiography (FA) capabilities of the company’s portable retinal camera Icon Go. The Scottsdale, Arizona, company sai...

9/22/2023
BreakingPharma
Precision Dropper Aims for Greater Patient Comfort, Less Waste
Precision Dropper Aims for Greater Patient Comfort, Less Waste

Precision Dropper, of Twin Falls, Idaho, on Sept. 15 introduced its universal adapter for eye drop bottles, designed to increase patient comfort and reduce waste when administering topical ocular m...

9/22/2023
BreakingGene TherapyIndustryRetina
Nanoscope Appoints Samuel Barone, MD, as Chief Medical Officer
Nanoscope Appoints Samuel Barone, MD, as Chief Medical Officer

Nanoscope Therapeutics, of Dallas, announced Sept. 21 that it had appointed Samuel Barone, MD, as chief medical officer. Barone was most recently chief medical officer at Gemini Therapeutics, prior...

9/21/2023
EarningsNewsletterRetinaRevenue
Ophthalmic Company Revenue in Q2-2023 Rises 1.5 Percent
Ophthalmic Company Revenue in Q2-2023  Rises 1.5 Percent

Ophthalmic manufacturer revenue in Q2-2023 totaled $11.4 billion. Most public companies reported above-average revenue in Q2-2023 compared with the past three years, while four public companies had...

Provider Surveys & Interviews

Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Table of Innovation

Choose Your Own Adventure

Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.

Safe, Secure & On Any Device

We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.

Pre-Qualified Invitations

We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.

Better Data = Better Decisions

A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.

Market Scope+ App Screen

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

United States
US Surveys
May select more than one